Drug profile · INN
fosaprepitant meglumine
PROEMEND
fosaprepitant meglumine (PROEMEND) is a neurokinin 1 receptor antagonist.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — fosaprepitant meglumine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
fosaprepitant meglumine (PROEMEND) is a neurokinin 1 receptor antagonist.
Key facts
INN fosaprepitant meglumine
Brand PROEMEND
Mechanism Neurokinin 1 receptor antagonist
Target Substance-P receptor
Mechanism of action
Neurokinin 1 receptor antagonist
Primary target: Substance-P receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is fosaprepitant meglumine?
fosaprepitant meglumine (PROEMEND) is a neurokinin 1 receptor antagonist.
What is the brand name for fosaprepitant meglumine?
PROEMEND is a marketed brand name for fosaprepitant meglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.